Effects of repeated antidepressant treatment on type 4A phosphodiesterase (PDE4A) in rat brain

Journal of Neurochemistry

Volumn 74, Issue 3, 2000, Pages 1257-1262

  Ye, Ying ^a   Jackson, Keasha ^a   O'Donnell, James M ^a,b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Desipramine; Fluoxetine; Phenelzine; Rolipram sensitive, low K(m), cyclic AMP phosphodiesterase; Trazodone; Adrenergic receptor

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; BRAIN ENZYME; CYCLIC AMP PHOSPHODIESTERASE; DESIPRAMINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PHENELZINE; PHOSPHODIESTERASE IV; ROLIPRAM; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY;

ANIMALIA;

EID: 0033952296     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.741257.x     Document Type: Article

References (33)

1. Akiyoshi J., Tsuchiyama K., Yamada K., Mizobe Y., Nakamura M., and Nagayama H. (1992) Effect of IAP and chronic antidepressant administration on the 5HT1A receptor in rat cortical membranes. Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 339-349.
2. 2 receptor mRNA in rat frontal cortex. J. Neurochem. 61, 1270-1276.
3. Cadogan A. K., Marsden C. A., Tulloch I., and Kendall D. A. (1993) Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig. Neuropharmacology 32, 249-256.
4. Challiss R. A. and Nicholson C. D. (1990) Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices. Br. J. Pharmacol. 99, 47-52.
5. Charney D. (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59, 11-14.
6. Fleischhacker W. W., Hinterhuber H., Bauer H., Pflug B., Berner P., Simhandl C., Wolf R., Gerlach W., Jaklitsch H., Sastre-y-Hernandez M., et al. (1992) A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology 26, 59-64.
7. Frazer A. and Conway P. (1984) Pharmacologic mechanisms of action of antidepressants. Psychiatr. Clin. North Am. 7, 575-586.
8. 2 and β-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. J. Neurochem. 62, 2262-2268.
9. Hrdina P. D. and Vu T. B. (1993) Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14, 324-331.
10. Klimek V., Zak-Knapik J., and Mackowiak M. (1994) Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J. Psychiatry Neurosci. 19, 63-67.
11. McManus D. J., Mousseau D. D., Paetsch P. R., Wishart T. B., and Greenshaw A. J. (1991) Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects. Biol. Psychiatry 30, 1122-1130.
12. McPhee I., Pooley L., Lobban M., Bolger G., and Houslay M. D. (1995) Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem. J. 310, 965-974.
13. O'Donnell J. M. (1990) Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol. J. Pharmacol. Exp. Ther. 254, 147-157.
14. O'Donnell J. M. (1993) Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate. J. Pharmacol. Exp. Ther. 264, 1168-1178.
15. O'Donnell J. M. and Frazer A. (1985) Effects of clenbuterol and antidepressant drugs on beta adrenergic receptor/N-protein coupling in the cerebral cortex of the rat. J. Pharmacol. Exp. Ther. 234, 30-36.
16. 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J. Pharmacol. Exp. Ther. 257, 681-690.
17. Paetsch P. R. and Greenshaw A. J. (1993) Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum. Mol. Chem. Neuropathol. 20, 21-31.
18. Palvimaki E. P., Laakso A., Kuoppamaki M., Syvalahti E., and Hietala J. (1994) Up-regulation of beta I-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology (Berl.) 115, 543-546.
19. Sette C., Vicini E., and Conti M. (1994) The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase J. Biol. Chem. 269, 18271-18274. [Published erratum appears in J. Biol. Chem. 269, 20806 (1994)].
20. Shakur Y., Wilson M., Pooley L., Lobban M., Griffiths S. L., Campbell A. M., Beattie J., Daly C., and Houslay M. D. (1995) Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. Biochem. J. 306, 801-809.
21. Siegel S. (1956) The case of two independent samples, in Nonparametric Statistics for the Behavioral Sciences (Morgan C. T., ed), pp. 95-158. McGraw-Hill, New York.
22. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85. [Published erratum appears in Anal. Biochem. 163, 279 (1987)].
23. Suda S., Nibuya M., Ishiguro T., and Suda H. (1998) Transcriptional and translational regulation of phosphodiesterase type IV isozymes in rat brain by electroconvulsive seizure and amidepressant drug treatment. J. Neurochem. 71, 1554-1563.
24. Swinnen J., Joseph D., and Conti M. (1989) The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl. Acad. Sci. USA 86, 8197-8201.
25. Takahashi M., Terwilliger R., Lane C., Mezes P., Conti M., and Duman R. (1999) Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J. Neurosci. 19, 610-618.
26. Torphy T. J., Zhou H. L., and Cieslinski L. B. (1992) Stimulation of beta adrenoceptors in a human monocyte cell line (U937) upregulates cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther. 263, 1195-1205.
27. Wachtel H. and Schneider H. H. (1986) Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology 25, 1119-1126.
28. Whalin M. E., Garrett R. L., Jr., Thompson W. J., and Strada S. J. (1988) Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices. Second Messengers Phosphoproteins 12, 311-325.
29. Winer B. (1971) Inference with respect to means and variance, in Statistical Principles in Experimental Design (Maytham W., Shapiro A., and Stern J., eds), pp. 4-54. McGraw-Hill, New York.
30. Ye Y. and O'Donnell J. M. (1996) Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex. J. Neurochem. 66, 1894-1902.
31. Ye Y., Conti M., Houslay M. D., Farooqui S. M., Chen M., and O'Donnell J. M. (1997) Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4) in rat brain. J. Neurochem, 69, 2397-2404.
32. m, cyclic AMP-specific phosphodiesterase in rat brain. Brain Res. Dev. Brain Res. 112, 11-19.
33. m, cyclic AMP specific phosphodiesterase in rat brain. Brain Res. Dev. Brain Res. 116, 181-189.